…
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Bath & Body Works (BBWI) is a U.S. specialty retailer focused on personal care, home fragrance and related accessories sold through a large store base and direct-to-consumer channels. Long-term growth may be supported by brand recognition, product innovation, expansion of omnichannel sales and loyalty-driven repeat purchases. These factors could appeal to investors seeking exposure to an established consumer-branded retailer with recurring demand patterns.
Principal risks include sensitivity to consumer discretionary spending, intense competition from specialty and online retailers, inventory and execution risk, and exposure to supply-chain disruptions and input-cost inflation.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Income before tax | 882.00M | 1028.00M | 1021.00M | 1045.00M | 1423.35M |
| Net income | 649.00M | 798.00M | 878.00M | 800.00M | 1333.48M |
| Selling general administrative | 2063.00M | 535.00M | 594.00M | 1879.00M | 1846.23M |
| Selling and marketing expenses | - | 1433.00M | 1357.00M | - | - |
| Gross profit | 3189.00M | 3234.00M | 3236.00M | 3255.00M | 3855.35M |
| Reconciled depreciation | 254.00M | 282.00M | 269.00M | 221.00M | 363.00M |
| Ebit | 1126.00M | 1340.00M | 1366.00M | 1376.00M | 1448.39M |
| Ebitda | 1380.00M | 1622.00M | 1635.00M | 1614.00M | 1811.39M |
| Depreciation and amortization | 254.00M | 282.00M | 269.00M | 238.00M | 363.00M |
| Non operating income net other | - | - | - | 17.00M | -198.00M |
| Operating income | 1126.00M | 1266.00M | 1285.00M | 1376.00M | 1448.39M |
| Other operating expenses | 6165.00M | 6041.00M | 6144.00M | 6184.00M | 5872.39M |
| Interest expense | 276.00M | 312.00M | 345.00M | 348.00M | 388.03M |
| Tax provision | 233.00M | 230.00M | 143.00M | 251.00M | 348.12M |
| Interest income | 276.00M | 312.00M | 345.00M | 348.00M | 388.00M |
| Net interest income | -276.00M | -312.00M | -345.00M | -348.00M | -388.03M |
| Extraordinary items | - | 0.00M | - | 6.00M | 258.00M |
| Income tax expense | 233.00M | 230.00M | 143.00M | 251.00M | 348.12M |
| Total revenue | 7291.00M | 7307.00M | 7429.00M | 7560.00M | 7881.51M |
| Total operating expenses | 2063.00M | 1968.00M | 1951.00M | 1879.00M | 1846.23M |
| Cost of revenue | 4102.00M | 4073.00M | 4193.00M | 4305.00M | 4026.16M |
| Total other income expense net | -244.00M | -238.00M | -264.00M | -331.00M | -25.03M |
| Discontinued operations | - | - | - | 6.00M | 258.25M |
| Net income from continuing ops | 649.00M | 798.00M | 878.00M | 794.00M | 1075.23M |
| Net income applicable to common shares | 649.00M | 798.00M | 878.00M | 800.00M | 1333.48M |
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Total assets | 5069.00M | 4872.00M | 5463.00M | 5494.00M | 6026.00M |
| Intangible assets | 165.00M | 165.00M | 165.00M | 165.00M | 165.00M |
| Other current assets | 187.00M | 210.00M | 97.00M | 99.00M | 81.00M |
| Total liab | 6348.00M | 6255.00M | 7089.00M | 7699.00M | 7543.00M |
| Total stockholder equity | -1279.00M | -1385.00M | -1627.00M | -2205.00M | -1518.00M |
| Deferred long term liab | - | - | - | 168.00M | 157.00M |
| Other current liab | 651.00M | 387.00M | 464.00M | 552.00M | 537.00M |
| Common stock | 108.00M | 115.00M | 120.00M | 122.00M | 134.00M |
| Capital stock | 108.00M | 115.00M | 120.00M | 122.00M | 134.00M |
| Retained earnings | -1435.00M | -1578.00M | -1838.00M | -2401.00M | -1803.00M |
| Other liab | - | - | - | 444.00M | 410.00M |
| Good will | 628.00M | 628.00M | 628.00M | 628.00M | 628.00M |
| Other assets | 151.00M | 60.00M | - | 68.00M | 68.00M |
| Cash | 953.00M | 674.00M | 1084.00M | 1232.00M | 1979.00M |
| Cash and equivalents | 953.00M | 674.00M | - | 1232.00M | 1979.00M |
| Total current liabilities | 1591.00M | 1231.00M | 1289.00M | 1379.00M | 1290.00M |
| Current deferred revenue | - | 197.00M | 198.00M | 195.00M | 148.00M |
| Net debt | 4001.00M | 4285.00M | 4489.00M | 4821.00M | 4034.00M |
| Short term debt | 475.00M | 192.00M | 362.00M | 177.00M | 170.00M |
| Short long term debt | 280.00M | - | - | - | - |
| Short long term debt total | 4954.00M | 4959.00M | 5573.00M | 6053.00M | 6013.00M |
| Other stockholder equity | -28.00M | 7.00M | 16.00M | -4.00M | 71.00M |
| Property plant equipment | 2068.00M | 2076.00M | - | 1193.00M | 1009.00M |
| Total current assets | 2019.00M | 1823.00M | 2115.00M | 2266.00M | 3009.00M |
| Net tangible assets | - | - | - | -1985.00M | -2469.00M |
| Net receivables | 180.00M | 205.00M | 224.00M | 226.00M | 240.00M |
| Long term debt | 3612.00M | 3884.00M | 4388.00M | 4862.00M | 4854.00M |
| Inventory | 699.00M | 734.00M | 710.00M | 709.00M | 709.00M |
| Accounts payable | 465.00M | 338.00M | 380.00M | 455.00M | 435.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 1.00M | 1.00M |
| Accumulated other comprehensive income | 74.00M | 71.00M | 75.00M | 78.00M | 80.00M |
| Common stock total equity | - | - | - | 122.00M | 134.00M |
| Retained earnings total equity | - | - | - | -2401.00M | -1803.00M |
| Treasury stock | - | - | - | -822.00M | -822.00M |
| Non currrent assets other | 39.00M | 24.00M | 15.00M | 155.00M | 149.00M |
| Non current assets total | 3050.00M | 3049.00M | 3348.00M | 3228.00M | 3017.00M |
| Capital lease obligations | 1062.00M | 1075.00M | 1185.00M | 1191.00M | 1159.00M |
| Long term debt total | 3612.00M | 3884.00M | - | 4862.00M | 4854.00M |
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Investments | - | -162.00M | -286.00M | -328.00M | -259.00M |
| Change to liabilities | - | - | - | 83.00M | -158.00M |
| Total cashflows from investing activities | -227.00M | -162.00M | - | -328.00M | -259.00M |
| Net borrowings | -14.00M | -539.00M | - | -9.00M | -1716.00M |
| Total cash from financing activities | -599.00M | -1132.00M | -815.00M | -1562.00M | -3188.00M |
| Change to operating activities | - | - | - | -26.00M | -91.00M |
| Net income | 649.00M | 798.00M | 878.00M | 800.00M | 1333.00M |
| Change in cash | 279.00M | -410.00M | -148.00M | -747.00M | -1954.00M |
| Begin period cash flow | 674.00M | 1084.00M | 1232.00M | 1979.00M | 3933.00M |
| End period cash flow | 953.00M | 674.00M | 1084.00M | 1232.00M | 1979.00M |
| Total cash from operating activities | 1102.00M | 886.00M | 954.00M | 1144.00M | 1492.00M |
| Depreciation | 254.00M | 282.00M | 269.00M | 221.00M | 363.00M |
| Other cashflows from investing activities | 10.00M | 63.00M | - | 0.00M | 11.00M |
| Dividends paid | 167.00M | 177.00M | 182.00M | 186.00M | 120.00M |
| Change to inventory | 37.00M | -26.00M | -2.00M | 0.00M | -177.00M |
| Change to account receivables | 25.00M | 18.00M | 2.00M | 11.00M | -64.00M |
| Sale purchase of stock | -401.00M | -401.00M | -148.00M | -1312.00M | -1964.00M |
| Other cashflows from financing activities | -17.00M | -15.00M | -23.00M | -55.00M | 624.00M |
| Change to netincome | - | - | - | 55.00M | 286.00M |
| Capital expenditures | 237.00M | 226.00M | 298.00M | 328.00M | 270.00M |
| Change receivables | - | - | - | 11.00M | -64.00M |
| Cash flows other operating | - | - | - | -26.00M | -91.00M |
| Exchange rate changes | - | - | - | - | 1.00M |
| Cash and cash equivalents changes | - | - | - | -746.00M | -1954.00M |
| Change in working capital | 113.00M | -93.00M | -82.00M | 68.00M | -490.00M |
| Stock based compensation | 31.00M | 40.00M | 43.00M | 38.00M | 46.00M |
| Other non cash items | 23.00M | -29.00M | -26.00M | 1144.00M | 195.00M |
| Free cash flow | 865.00M | 660.00M | 656.00M | 816.00M | 1222.00M |
Sector: Consumer Cyclical Industry: Specialty Retail
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BBWI Bath & Body Works Inc. |
-0.53 2.44% |
21.19 | 4.70 | 6.60 | 0.47 | 1403.38 | 1.05 | 5.09 |
| ANCTF Alimentation Couchen Tard Inc A |
1.28 2.25% |
58.16 | 17.19 | 18.25 | 0.65 | 3.25 | 0.82 | 9.12 |
| CASY Caseys General Stores Inc |
-3.50 0.49% |
710.61 | 44.85 | 39.84 | 1.71 | 7.50 | 1.84 | 22.43 |
| ULTA Ulta Beauty Inc |
-4.73 0.72% |
654.35 | 19.96 | 19.68 | 1.80 | 8.87 | 1.99 | 13.26 |
| TSCO Tractor Supply Company |
0.27 0.73% |
37.01 | 17.20 | 14.99 | 1.09 | 6.70 | 1.52 | 12.94 |
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
| Name | Title | Year Born |
|---|---|---|
| Ms. Julie B. Rosen | Pres | 1966 |
| Ms. Wendy C. Arlin | Exec. VP & CFO | 1971 |
| Ms. Deon N. Riley | Chief HR Officer | 1968 |
| Ms. Gina R. Boswell | CEO & Director | 1963 |
| Ms. Amie Preston | Chief Investor Relations Officer | NA |
| Mr. Michael C. Wu | Chief Legal Officer & Corp. Sec. | 1967 |
| Mr. Bruce A. Soll | Sr. VP & Counsel of Company Affairs | 1958 |
| Mr. Edward G. Razek | Pres of Brand & Creative Services and Chief Marketing Officer of Brand & Creative Services | NA |
| Mr. Brian K. Leinbach | Exec. VP & CIO | NA |
| Mr. Tom Mazurek | Chief Supply Chain Officer - Supply Chain Operations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.